The prostate cancer research team led by Dr. Peter Pinto at the National Cancer Institute has just published some interesting new information on risk for disease progression in men on active surveillance. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active, biopsy, follow-up, MRI/TRUS fusion, risk, surveillance | Leave a comment »
An article just published in the Journal of Urology argues that, ” The gold standard for cancer detection in primary biopsy is [now] a combination of systematic and targeted cores.” . READ MORE …
Filed under: Diagnosis, Risk | Tagged: biopsy, MRI, MRI/TRUS fusion, systematic, targeted | 1 Comment »
There is a distinctly “odd” paper in the December 2014 issue of the Journal of Urology on optimization of the use of MRI/TRUS fusion-guided biopsies in men suspected of having prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: biopsy, cutoff, MRI/TRUS fusion, PSA, targeted | 3 Comments »
Two newly published papers in the November issue of the Journal of Urology address prospective studies of the use of differing forms of MRI-guided biopsy in the diagnosis of prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: accuracy, biopsy, MRi-guided, MRI/TRUS fusion, TRUS-guided | 5 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 